Edition:
India

CHF Solutions Inc (CHFS.OQ)

CHFS.OQ on NASDAQ Stock Exchange Capital Market

0.68USD
1:30am IST
Change (% chg)

$-0.04 (-5.93%)
Prev Close
$0.73
Open
$0.65
Day's High
$0.69
Day's Low
$0.62
Volume
1,607,562
Avg. Vol
1,289,689
52-wk High
$2.90
52-wk Low
$0.30

Select another date:

Thu, Jul 9 2020

BRIEF-CHF Solutions & Renalsense Enter Distribution Partnership To Offer Ultrafiltration And Real-Time Renal Diagnostics

* CHF SOLUTIONS AND RENALSENSE ENTER DISTRIBUTION PARTNERSHIP TO OFFER ULTRAFILTRATION AND REAL-TIME RENAL DIAGNOSTICS

BRIEF-CHF Solutions Files Prospectus Related To Resale Of Shares

* CHF SOLUTIONS INC FILES PROSPECTUS RELATES TO RESALE, FROM TIME TO TIME 1.8 MILLION SHARES OF COMMON STOCKISSUABLE UPON EXERCISE OF WARRANTS

BRIEF-CHF Solutions Expands Commercial Presence In The Middle East With Distribution Arrangement For UAE

* CHF SOLUTIONS EXPANDS COMMERCIAL PRESENCE IN THE MIDDLE EAST WITH DISTRIBUTION ARRANGEMENT FOR UNITED ARAB EMIRATES Source text for Eikon: Further company coverage:

BRIEF-CHF Solutions. Announces Registered Direct Offering Priced At-The-Market

* CHF SOLUTIONS, INC. ANNOUNCES REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

BRIEF-CHF Solutions Intends To Effect Reverse Stock Split

* CHF SOLUTIONS INC - INTENDS TO EFFECT A REVERSE STOCK SPLIT IF NECESSARY TO MAINTAIN COMPLIANCE WITH MINIMUM BID PRICE RULE Source text: (https://bit.ly/2Vze1c1) Further company coverage:

BRIEF-CHF Solutions Receives $1.66 Million Under SBA's Paycheck Protection Program

* CHF SOLUTIONS RECEIVES $1.66 MILLION UNDER SBA'S PAYCHECK PROTECTION PROGRAM AND $1.1 MILLION FROM WARRANT EXERCISES

BRIEF-CHF Solutions Announces Covid-19 Patients Treated With Aquadex Therapy For Fluid Management When Access To Dialysis Machines Is Limited Or Not Available

* CHF SOLUTIONS ANNOUNCES COVID-19 PATIENTS TREATED WITH AQUADEX THERAPY FOR FLUID MANAGEMENT WHEN ACCESS TO DIALYSIS MACHINES IS LIMITED OR NOT AVAILABLE Source text for Eikon: Further company coverage:

BRIEF-CHF Solutions Submits Patent Application For System For Rapid Clearing Of Cytokines In COVID-19 Patients

* CHF SOLUTIONS SUBMITS PATENT APPLICATION FOR HEMOFILTRATION SYSTEM FOR RAPID CLEARING OF CYTOKINES IN COVID-19 PATIENTS Source text for Eikon: Further company coverage:

BRIEF-CHF Solutions Prices Registered Direct Offering Priced At-The-Market

* CHF SOLUTIONS, INC. ANNOUNCES PRICING OF REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

BRIEF-CHF Solutions Expects Increased Demand For Ultrafiltration Therapy

* CHF SOLUTIONS - EXPECTS INCREASED DEMAND FOR ULTRAFILTRATION THERAPY AS RATE OF AFFECTED PATIENTS THAT ARE INFECTED WITH COVID-19 LIKELY TO INCREASE Source text for Eikon: Further company coverage:

Select another date: